<DOC>
	<DOCNO>NCT00642135</DOCNO>
	<brief_summary>Pupillary dilation perform fundus premature newborns neonate often difficult obtain , non mature iris sphincter . The fundus essential detect retinal anomaly ( retinopathy prematurity chorioretinal disk anomaly ) . The aim study obtain satisfactory degree mydriasis minimal dose two mydriatic treatment , optimal duration good tolerance drug . The study evaluate mydriasis premature newborn , neonates infant justify mydriasis bilateral diagnosis fundus , use ophthalmic insert Mydriasert® versus reference treatment ( association phenylephrine tropicamide eyedrop ) . Ophthalmic insert Mydriasert® control drug dispensation decrease number nurse intervention obtain mydriasis patient .</brief_summary>
	<brief_title>CLAIR -FO : Clinical Trial Ophthalmic Insert Mydriasert® Versus Reference Treatment</brief_title>
	<detailed_description>The aim study obtain satisfactory degree mydriasis minimal dose two mydriatic treatment , optimal duration good tolerance drug . The study evaluate mydriasis premature newborn , neonates infant justify mydriasis bilateral diagnosis fundus , use ophthalmic insert Mydriasert® versus reference treatment ( association phenylephrine tropicamide eyedrop ) . Ophthalmic insert Mydriasert® control drug dispensation decrease number nurse intervention obtain mydriasis patient .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Tropicamide</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Premature newborn , neonates infant less 18 monthsold indoor neonatology clinical department Robert Debre Hospital cardiologic monitor Presenting risk retinopathy prematurity fundus anomaly ( chorioretinal and/or disk anomaly ) . Needing bilateral fundus Parents , tutor legal represent patient inform objective study give write consent . Covered French social security CMU Neonates less 1000g inclusion Premature newborn less 30 week gestational age inclusion Contraindication one evaluate drug Any treatment could provoke dangerous drug interaction patient associate one drug study Anatomical predisposition glaucoma , hypertension contraindication note physician</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>premature</keyword>
	<keyword>neonate</keyword>
	<keyword>infant</keyword>
	<keyword>child</keyword>
	<keyword>Mydriasert®</keyword>
	<keyword>mydriasis</keyword>
	<keyword>fundus</keyword>
	<keyword>Tropicamide</keyword>
	<keyword>Phenylephrine</keyword>
	<keyword>clinical trial</keyword>
	<keyword>Infant</keyword>
	<keyword>premature newborn</keyword>
	<keyword>bilateral diagnosis fundus</keyword>
</DOC>